Use of high-dose oxazaphosphorine drugs for treating immune disorders

Details for Australian Patent Application No. 2006320162 (hide)

Owner The Johns Hopkins University

Inventors Jones, Richard J.; Brodsky, Robert A.

Agent FB Rice

Pub. Number AU-A-2006320162

PCT Pub. Number WO2007/065167

Priority 60/742,172 02.12.05 US

Filing date 4 December 2006

Wipo publication date 7 June 2007

International Classifications

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61P 21/04 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

19 June 2008 PCT application entered the National Phase

  PCT publication WO2007/065167 Priority application(s): WO2007/065167

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006320167-Methods for altering stool quality and/or stool frequency

2006320139-Iminopropene compound and use thereof